Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-03-13FDA Approved: CALCIUM ACETATE — Original Application (SQUARE PHARMACEUTICALS LIMITED)
The FDA approved Square Pharmaceuticals Limited's original application for calcium acetate, making a generic version of this phosphate binde…
-
FDA approval · 2023-01-30FDA Approved: TECHNETIUM TC 99M MERTIATIDE — Original Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
The FDA approved Technetium Tc-99m mertiatide (NDA216820) for renal imaging in an original application from Jubilant Radiopharma, enabling a…
-
FDA approval · 2022-12-16FDA Approved: FUROSEMIDE — Original Application (Lifestar Pharma LLC)
FDA approved Lifestar Pharma LLC's original application for furosemide, authorizing the generic version of the diuretic for its labeled indi…
-
FDA approval · 2022-10-24FDA Approved: METOLAZONE — Original Application (Ingenus Pharmaceuticals LLC)
FDA approves Metolazone via Original Application for a generic version by Ingenus Pharmaceuticals LLC. The approval supports its use for ede…
-
FDA approval · 2022-08-31FDA Approved: FUROSEMIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for furosemide from Hospira, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-08-04FDA Approved: BUMETANIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original ANDA for bumetanide (generic) by Novadoz Pharmaceuticals LLC for use in edema associated with congestive heart fai…
-
FDA approval · 2022-07-20FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Lanthanum carbonate.
-
FDA approval · 2022-06-16FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
FDA approved a supplemental application for Feraheme (ferumoxytol) from AMAG Pharmaceuticals.
-
FDA approval · 2022-05-25FDA Approved: SEVELAMER CARBONATE FOR ORAL SUSPENSION — Supplemental Application (Dr. Reddys Laboratories Inc)
FDA approved a supplemental application for Sevelamer carbonate for oral suspension from Dr. Reddy's Laboratories, enabling a generic formul…
-
FDA approval · 2022-04-25FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals' supplemental application for sevelamer carbonate, enabling its generic product to be marketed.…
-
FDA approval · 2022-04-05FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Sevelamer carbonate by Aurobindo Pharma Limited. This approval enables the generic product to be…
-
FDA approval · 2022-02-07FDA Approved: SEVELAMER CARBONATE — Original Application (Micro Labs Limited)
FDA approved the original ANDA for Sevelamer carbonate from Micro Labs Limited, enabling a generic version of the phosphate binder used to t…
-
FDA approval · 2022-01-27FDA Approved: LANTHANUM CARBONATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's lanthanum carbonate generic product for reducing phosphate levels in patients with end-stage renal disease on dialysis. …
-
FDA approval · 2022-01-24FDA Approved: DOXERCALCIFEROL — Original Application (Eugia US LLC)
FDA approved an original application for doxercalciferol (generic) by Eugia US LLC.
-
FDA approval · 2022-01-24FDA Approved: LANTHANUM CARBONATE — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s generic lanthanum carbonate (original application) for the treatment of hyperphosphatemia in adults with chron…
-
FDA approval · 2022-01-07FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Sevelamer Carbonate submitted by Bionpharma Inc.
-
FDA approval · 2021-07-09FDA Approved: KERENDIA — Original Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approves Kerendia (finerenone) from the original application for adults with chronic kidney disease due to type 2 diabetes mellitus. It …
-
FDA approval · 2021-05-17FDA Approved: SEVELAMER CARBONATE — Original Application (Bionpharma Inc.)
FDA approved the original application for sevelamer carbonate from Bionpharma Inc., a generic phosphate binder for managing hyperphosphatemi…
-
FDA approval · 2021-03-10FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Ferric Citrate from Mylan Pharmaceuticals, approving a supplemental NDA for the product (NDA…
-
FDA approval · 2021-03-02FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for ZEMPLAR (paricalcitol) submitted by AbbVie Inc.
-
FDA approval · 2021-01-26FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approves a supplemental application for DELFLEX, a dialysis solution containing dextrose monohydrate and electrolytes, manufactured by F…
-
FDA approval · 2021-01-20FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
The FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc.
-
FDA approval · 2021-01-15FDA Approved: FERUMOXYTOL — Original Application (Sandoz Inc)
The FDA approved a generic version of ferumoxytol from Sandoz (Original Application), providing a generic option for iron deficiency anemia …
-
FDA approval · 2021-01-04FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Sevelamer Carbonate by Amneal Pharmaceuticals LLC.
-
FDA approval · 2020-12-28FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Sevelamer carbonate submitted by Exelan Pharmaceuticals Inc.